| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rain Oncology Inc. | Chairman and CEO, Director | Common Stock, par value $0.001 per share | 0 | $0 | $1.21 | Jan 26, 2024 | Direct |
| Rain Oncology Inc. | Chairman and CEO, Director | Stock Option (Right to Buy) | 0 | Jan 26, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RAIN | Rain Oncology Inc. | Jan 26, 2024 | 8 | $0 | 4 | Jan 26, 2024 | Chairman and CEO, Director |
| RAIN | Rain Oncology Inc. | Aug 9, 2023 | 2 | $0 | 4 | Aug 11, 2023 | Chairman and CEO, Director |
| RAIN | Rain Oncology Inc. | Feb 15, 2023 | 1 | $0 | 4 | Feb 17, 2023 | Chairman and CEO, Director |
| RAIN | Rain Therapeutics Inc. | Jun 1, 2022 | 1 | $57.3K | 4 | Jun 2, 2022 | Chairman and CEO, Director, 10%+ Owner |
| RAIN | Rain Therapeutics Inc. | Apr 14, 2022 | 2 | $0 | 4 | Apr 15, 2022 | Chairman and CEO, Director, 10%+ Owner |
| RAIN | Rain Therapeutics Inc. | Mar 11, 2022 | 2 | $57.9K | 4 | Mar 15, 2022 | President and CEO, Director |
| RAIN | Rain Therapeutics Inc. | Feb 2, 2022 | 1 | $0 | 4 | Feb 4, 2022 | President and CEO, Director |